Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Mesoblast (MESO) over the last 11 years, with Q2 2025 value amounting to $84.6 million.

  • Mesoblast's Total Non-Current Liabilities fell 2677.51% to $84.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $84.6 million, marking a year-over-year decrease of 2677.51%. This contributed to the annual value of $84.6 million for FY2025, which is 2677.51% down from last year.
  • As of Q2 2025, Mesoblast's Total Non-Current Liabilities stood at $84.6 million, which was down 2677.51% from $119.3 million recorded in Q4 2024.
  • Mesoblast's 5-year Total Non-Current Liabilities high stood at $130.2 million for Q4 2023, and its period low was $66.6 million during Q1 2021.
  • Over the past 5 years, Mesoblast's median Total Non-Current Liabilities value was $113.2 million (recorded in 2022), while the average stood at $104.1 million.
  • In the last 5 years, Mesoblast's Total Non-Current Liabilities tumbled by 3419.85% in 2021 and then skyrocketed by 6860.87% in 2022.
  • Mesoblast's Total Non-Current Liabilities (Quarter) stood at $111.0 million in 2021, then rose by 2.26% to $113.5 million in 2022, then increased by 14.72% to $130.2 million in 2023, then decreased by 8.36% to $119.3 million in 2024, then fell by 29.08% to $84.6 million in 2025.
  • Its Total Non-Current Liabilities was $84.6 million in Q2 2025, compared to $119.3 million in Q4 2024 and $115.6 million in Q2 2024.